Redefining the role(s) of endothelial αvβ3-integrin in angiogenesis. (Q38268451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Redefining the role(s) of endothelial αvβ3-integrin in angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Tim S Ellison

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Stephen Douglas Robinson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Veronica Steri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Emma Gould

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

Biochemical Society Transactions

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1590-1595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

Requirement of vascular integrin alpha v beta 3 for angiogenesis

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrins: molecular targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

The role of β3-integrins in tumor angiogenesis: context is everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin signaling is critical for pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

The role of the alphaVbeta3 integrin in the development of osteolytic bone metastases: a pharmacological target for alternative therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin targeted delivery of chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin alpha(v)beta(3)-Targeted Cancer Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

Molecular Dynamics Reveal that isoDGR-Containing Cyclopeptides Are True αvβ3 Antagonists Unable To Promote Integrin Allostery and Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140206

21 January 2018

Identifiers

DOI

10.1042/BST20140206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399575%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference